Paclitaxel Oral Solution

DRUG2 trials

Sponsors

Shanghai Pulmonary Hospital, Shanghai, China, Anhui Provincial Cancer Hospital

Conditions

Extensive-stage Small Cell Lung Cancer (ES-SCLC)Neoadjuvant TherapyNon-Small-Cell Lung CancerPaclitaxelSquamous Non-Small Cell Lung Cancer sqNSCLC

Phase 4

Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)

RecruitingNCT07744698

Anhui Provincial Cancer HospitalExtensive-stage Small Cell Lung Cancer (ES-SCLC), Squamous Non-Small Cell Lung Cancer sqNSCLC

Start: 2026-07-24End: 2029-06-01Target: 107Updated: 2026-08-04

Unknown Phase

Oral Paclitaxel as Neoadjuvant Therapy in Elderly NSCLC: A Phase II Trial

Not yet recruitingNCT07599163

Shanghai Pulmonary Hospital, Shanghai, ChinaNeoadjuvant Therapy, Non-Small-Cell Lung Cancer, Paclitaxel

Start: 2026-06-08End: 2030-12-30Target: 75Updated: 2026-05-20